Author

Saradha Rajamani

Observed name: S. Rajamani

Institution: University of Utah

Observed institutions: University of Iowa, University of Utah, Myriad Genetics

OpenAlex ID: A5014515399

Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy

2019 · Daniel J. Canter, Stephen Freedland, et al. · Prostate Cancer and Prostatic Diseases · 38

Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance

2018 · Daniel W. Lin, E. David Crawford, et al. · Urologic Oncology Seminars and Original Investigations · 37

Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate Cancer

2018 · Daniel J. Canter, Julia Reid, et al. · European Urology · 30

The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation

2021 · Jonathan Tward, Lauren Lenz, et al. · International Journal of Radiation Oncology*Biology*Physics · 25

Automating Ground Truth Annotations for Gland Segmentation Through Immunohistochemistry

2023 · Tushar Kataria, Saradha Rajamani, et al. · Modern Pathology · 21

Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection

2015 · Eric J. Askeland, Vincent A. Chehval, et al. · Cancer Biomarkers · 19

Analytical Validation of a 12-Gene Molecular Test for the Prediction of Distant Recurrence in Breast Cancer

2017 · M Bryan Warf, Saradha Rajamani, et al. · Future Science OA · 12

Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy

2021 · Jack M. Cuzick, Steven Stone, et al. · Cancer Reports · 6

Molecular genetic testing for large genomic deletion and duplication mutations in the BRCA1 and BRCA2 genes for hereditary breast and ovarian cancer

2007 · R. Wenstrup, T. Judkins, et al. · Journal of Clinical Oncology · 3

Cell cycle progression score and PTEN as prognostic factors for metastasis in intermediate- and high-risk prostate cancer overall, and in those who also received salvage radiotherapy.

2021 · Bruce J. Trock, Saradha Rajamani, et al. · Journal of Clinical Oncology

Cell cycle progression score differentiates indolent from aggressive prostate cancer in men diagnosed by TURP.

2019 · Jack M. Cuzick, Steven Stone, et al. · Journal of Clinical Oncology

Cell cycle progression score and PTEN as prognostic factors for metastasis in intermediate and high-risk prostate cancer.

2019 · Bruce J. Trock, Saradha Rajamani, et al. · Journal of Clinical Oncology

Evaluating cell cycle progression score as a prognostic marker for non-muscle invasive bladder cancer (NMIBC).

2018 · Christopher J. Weight, Paari J Murugan, et al. · Journal of Clinical Oncology

Mp36-05 Cell Cycle Progression Score Predicts Metastatic Progression of Clear Cell Renal Cell Carcinoma After Resection

2014 · Eric Askeland, Vincent Chehval, et al. · The Journal of Urology

Cell cycle progression score to predict metastatic progression of clear cell renal cell carcinoma after resection.

2014 · Eric J. Askeland, Vincent A. Chehval, et al. · Journal of Clinical Oncology

Quantitative multiplex PCR analysis for large rearrangements in the MLH1 and MSH2 genes for hereditary non- polyposis colorectal cancer

2007 · B. Roa, T. Judkins, et al. · Journal of Clinical Oncology

Works count: 16

Citation count: 191

H-index: 7

I10-index: 7